Work With Your Doctor to Get Blenrep (Belantamab Mafodotin) Approved by UnitedHealthcare in Michigan: Complete Provider Collaboration Guide
Answer Box: Blenrep (belantamab mafodotin) is currently only available through GSK's compassionate use program after FDA withdrawal in 2022. UnitedHealthcare requires prior authorization for specialty oncology drugs, with 85% appeal success rates through peer-to-peer review. First step: Contact your oncologist to verify eligibility for compassionate use (4+ prior